Atherosclerosis is a slowly progressive disease. Therefore, surrogate end-p
oints are used in cardiovascular trials. Of the techniques currently in use
, intima-media thickness measurement and flow-mediated vasodilatation are r
eviewed, and the results obtained with these techniques placed in a clinica
l perspective.